Radiomics study for predicting the expression of PD-L1 in non -small cell lung cancer based on CT images and clinicopathologic features

被引：4
|
作者：
Sun, Zongqiong [1 ,2 ]
Hu, Shudong [2 ]
Ge, Yuxi [2 ]
Wang, Jun [3 ]
Duan, Shaofeng [4 ]
Song, Jiayang [4 ]
Hu, Chunhong [1 ]
Li, Yonggang [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Dept Radiol, Suzhou 215006, Jiangsu, Peoples R China
[2] Jiangnan Univ, Affiliated Hosp, Dept Radiol, Wuxi, Jiangsu, Peoples R China
[3] Shanghai Univ, Shanghai Inst Adv Commun & Data Sci, Sch Commun & Informat Engn, Shanghai, Peoples R China
[4] Gen Elect GE Healthcare China, Shanghai, Peoples R China
来源：
JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY | 2020年 / 28卷 / 03期
基金：
中国国家自然科学基金;
关键词：
IMMUNOTHERAPY; BIOMARKERS; CHALLENGES; STATISTICS; RISK;
D O I：
暂无
中图分类号：
TH7 [仪器、仪表];
学科分类号：
0804 ; 080401 ; 081102 ;
摘要：
引用
收藏
页码：449 / 459
页数：11
相关论文
共 50 条
  • [1] Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features
    Sun Z.
    Hu S.
    Ge Y.
    Wang J.
    Duan S.
    Song J.
    Hu C.
    Li Y.
    Li, Yonggang (liyonggang224@163.com), 1600, IOS Press BV (28): : 449 - 459
  • [2] Qualitative analysis of PD-L1 expression in non-small-cell lung cancer based on chest CT radiomics
    Fu, Yu
    Zhang, Hong
    Xue, Peng
    Ren, Meirong
    Xiao, Taohui
    Zhang, Zhili
    Huang, Yong
    Dong, Enqing
    BIOMEDICAL SIGNAL PROCESSING AND CONTROL, 2023, 84
  • [3] Prediction of PD-L1 expression rate in non-small cell lung cancer based on CT-radiomics
    Xi, Lihong
    Yang, Lingya
    He, Xiaofeng
    Huang, Jingling
    Li, Jun
    Zhong, Daquan
    Huang, Haipeng
    Li, Jiabin
    Zhai, Tiantian
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S5015 - S5019
  • [4] PD-L1 expression testing in non-small cell lung cancer
    Teixido, Cristina
    Vilarino, Noelia
    Reyes, Roxana
    Reguart, Noemi
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [5] Quantification of PD-L1 expression in non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S402 - S404
  • [6] Clinicopathological significance of the expression of PD-L1 in non-small cell lung cancer
    Montero, M. Angeles
    Aricak, Ozan
    Kis, Lorand
    Yoshikawa, Akira
    De Petris, Luigi
    Grundberg, Oscar
    Pham, Hoa H. N.
    Roden, Anja C.
    Fukuoka, Junya
    Attanoos, Richard
    Guijarro, Ricardo
    Alarcon, Felix
    Lindstrom, Kati
    Ortiz-Villalon, Cristian
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2021, 51
  • [7] Predictions of PD-L1 Expression Based on CT Imaging Features in Lung Squamous Cell Carcinoma
    Yeo, Seong Hee
    Yoon, Hyun Jung
    Kim, Injoong
    Kim, Yeo Jin
    Lee, Young
    Cha, Yoon Ki
    Bak, So Hyeon
    JOURNAL OF THE KOREAN SOCIETY OF RADIOLOGY, 2024, 85 (02): : 394 - 408
  • [8] Spatial heterogeneity of PD-L1 expression and the risk for misclassification of PD-L1 immunohistochemistry in non-small cell lung cancer
    Dori, Shani Ben
    Aizic, Asaf
    Sabo, Edmond
    Hershkovitz, Dov
    LUNG CANCER, 2020, 147 : 91 - 98
  • [9] Biomarkers for PD-1/PD-L1 Blockade Therapy in Non-Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?
    Chae, Young Kwang
    Pan, Alan
    Davis, Andrew A.
    Raparia, Kirtee
    Mohindra, Nisha A.
    Matsangou, Maria
    Giles, Francis J.
    CLINICAL LUNG CANCER, 2016, 17 (05) : 350 - 361
  • [10] Targeting PD-L1 for non-small-cell lung cancer
    Feld, Emily
    Horn, Leora
    IMMUNOTHERAPY, 2016, 8 (06) : 747 - 758
12345